Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis

Human T-cell lymphotropic virus type I (HTLV-1) infection is associated with a diverse range of 4,lymphoproliferative and neurodegenerative diseases, yet pathogenic mechanisms induced by the virus remain obscure. This complex retrovirus contains typical structural and enzymatic genes but also unique regulatory, and accessory genes in four open reading frames (ORFs) of the pX region of the viral genome (pX ORFs I to IV). The regulatory proteins its encoded by pX ORFs III and IT, Tax and Rex, respectively, have been extensively characterized. In contrast the contribution of the four accessory proteins p12(I), p27(I), p13(II), and p30(II) encoded by pX ORFs I and 11, to viral replication and pathogenesis remained unclear. Proviral clones that are mutated in either pX ORF I or 11, while fully competent in cell culture, are severely limited in their replicative capacity, in a rabbit model. Emerging evidence indicates that the HTLV-1 accessory, proteins are critical for establishment of viral infectivity, enhance T-lymphocyte activation, and potentially, alter gene transcription and mitochondrial function. HTLV-1, pX ORF I expression is critical to the viral infectivity, in resting primary lymphocytes, suggesting a role for p12(I) in lymphocyte activation. The endoplasmic reticulum and cis-Golgi localizing p12(I), encoded from pX ORF I, activates NFAT, a key T-cell transcription factor, through calcium-mediated signaling pathways and may, lower the threshold of lymphocyte activation via the JAK/STAT pathway. In contrast p30(II) localizes to the nucleus and represses viral promoter activity,, but may, regulate cellular gene expression through p300/CBP or related coactivators of transcription p13(II) targets mitochondrial proteins, where it alters the organelle morphology and may, influence energy metabolism. Collectively,, studies of the molecular functions of the HTLV-I accessory), proteins provide insight into strategies used by retroviruses that are associated with lymphoproliferative diseases.